| |
| |
|
| Insider
Information: |
Waugh Jacob |
| Relationship: |
Chief Scientific Officer |
| City: |
Newark |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
28,413 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$96,604 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
28,413 |
|
|
| Total
Value |
$96,604 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Revance Therapeutics, Inc. |
RVNC |
Chief Scientific Officer |
2015-05-19 |
28,413 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RVNC |
Revance Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2015-05-19 |
4 |
D |
$25.94 |
$81,218 |
D/D |
(3,131) |
28,413 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2015-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,544 |
31,544 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2014-09-17 |
4 |
OE |
$2.55 |
$538,386 |
D/D |
69,380 |
122,713 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2014-09-17 |
4 |
AS |
$20.58 |
$2,025,441 |
D/D |
(97,713) |
25,000 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2014-08-18 |
4 |
S |
$24.47 |
$611,675 |
D/D |
(25,000) |
53,333 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2014-05-19 |
4 |
A |
$32.22 |
$805,500 |
D/D |
25,000 |
78,333 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Chief Scientific OfficerOffice |
• – – |
2014-02-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
53,333 |
|
- |
|
7 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
